Quantum-Si (NASDAQ:QSI - Get Free Report) posted its quarterly earnings data on Monday. The company reported ($0.18) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.18), Zacks reports. Quantum-Si had a negative return on equity of 36.96% and a negative net margin of 3,968.84%.
Quantum-Si Stock Performance
NASDAQ:QSI traded down $0.08 during mid-day trading on Monday, reaching $1.30. The stock had a trading volume of 8,305,808 shares, compared to its average volume of 23,761,453. The stock has a market capitalization of $185.53 million, a P/E ratio of -2.03 and a beta of 2.69. The firm has a 50 day moving average price of $2.23 and a two-hundred day moving average price of $1.44. Quantum-Si has a one year low of $0.61 and a one year high of $5.77.
Analyst Ratings Changes
Several analysts have weighed in on the company. Canaccord Genuity Group lowered their price target on Quantum-Si from $1.50 to $1.00 and set a "hold" rating on the stock in a report on Wednesday, November 13th. Alliance Global Partners started coverage on shares of Quantum-Si in a research report on Friday, February 7th. They set a "buy" rating and a $3.75 target price for the company. Finally, HC Wainwright reissued a "buy" rating and issued a $5.50 price target on shares of Quantum-Si in a report on Tuesday, January 14th.
Check Out Our Latest Analysis on QSI
Insider Buying and Selling at Quantum-Si
In other news, Director Jonathan M. Rothberg sold 3,506,267 shares of the firm's stock in a transaction dated Friday, December 27th. The stock was sold at an average price of $3.34, for a total transaction of $11,710,931.78. Following the transaction, the director now directly owns 1,250,000 shares of the company's stock, valued at approximately $4,175,000. This trade represents a 73.72 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 30.04% of the company's stock.
Quantum-Si Company Profile
(
Get Free Report)
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Quantum-Si, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quantum-Si wasn't on the list.
While Quantum-Si currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
